Comments on Boelaert Et Al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS Versus ELISA. Toxins 2016, 8, 149
Overview
Overview
Journal
Toxins (Basel)
Publisher
MDPI
Specialty
Toxicology
Date
2016 Nov 2
PMID
27801791
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
n/a.
Citing Articles
Boelaert J, Schepers E, Glorieux G, Eloot S, Vanholder R, Lynen F Toxins (Basel). 2016; 8(11).
PMID: 27801792 PMC: 5127109. DOI: 10.3390/toxins8110312.
References
1.
Kurz H, Trunk H, Weitz B
. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. Arzneimittelforschung. 1977; 27(7):1373-80.
View
2.
Martens-Lobenhoffer J, Westphal S, Awiszus F, Bode-Boger S, Luley C
. Determination of asymmetric dimethylarginine: liquid chromatography-mass spectrometry or ELISA?. Clin Chem. 2005; 51(11):2188-9.
DOI: 10.1373/clinchem.2005.056788.
View
3.
Sitar M, Kayacelebi A, Beckmann B, Kielstein J, Tsikas D
. Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin. Amino Acids. 2015; 47(9):1983-93.
DOI: 10.1007/s00726-015-1991-4.
View
4.
Tsikas D, Sandmann J, Savva A, Luessen P, Boger R, Gutzki F
. Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 2000; 742(1):143-53.
DOI: 10.1016/s0378-4347(00)00142-0.
View
5.
Boelaert J, Schepers E, Glorieux G, Eloot S, Vanholder R, Lynen F
. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA. Toxins (Basel). 2016; 8(5).
PMC: 4885064.
DOI: 10.3390/toxins8050149.
View